SHPH - Shuttle Pharmaceuticals Holdings, Inc.
0.695
0 0%
Share volume: 300
Last Updated: Wed 05 Feb 2025 08:30:24 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.19%
PREVIOUS CLOSE
CHG
CHG%
$0.70
0.00
0.00%
Summary score
6%
Profitability
0%
Dept financing
43%
Liquidity
15%
Performance
0%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-278.27%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
168.6%
Debt ratio change over timeo
0%
Current Ratio
1.59%
Quick Ratio
0%
Cash Position Ratio
0.52%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-278.27%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
168.6%
Debt ratio change over timeo
0%
Current Ratio
1.59%
Quick Ratio
0%
Cash Position Ratio
0.52%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-26.48%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
41.91%
Debt ratio change over time
0%
Current Ratio
2.96%
Quick Ratio
0%
Cash Position Ratio
0.94%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | SHPH | ABBV | AMGN | VRTX |
|---|---|---|---|---|
| Return on equity | 0% | 13.03% | 18.15% | 6.63% |
| Return on assets | -278.27% | 2.33% | 3.24% | 5.84% |
| Return on sales | 0% | 28.06% | 32.46% | 43.41% |
| Return on invested capital | 0% | 2.07% | 5.53% | 34.89% |
| Profitability | 0% | 46% | 62% | 84% |
| Total debt ratio | 168.6% | 90.46% | 90.54% | 24.67% |
| Debt ratio change over time | 0% | 435.59% | 17.23% | -0.06% |
| Dept financing | 25% | 38% | 14% | 4% |
| Current Ratio | 1.59% | 0.9% | 1.54% | 3.64% |
| Quick Ratio | 0% | 0.8% | 1.06% | 3.42% |
| Cash Position Ratio | 0.52% | 0.39% | 0.54% | 2.77% |
| Liquididy | 13% | 13% | 28% | 75% |
| Short-term ratios | SHPH | ABBV | AMGN | VRTX |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 5.91% |
| Return on assets | -278.27% | 1.33% | 1.27% | 4.97% |
| Return on sales | 0% | 22.54% | 14.41% | 42.59% |
| Return on invested capital | 0% | 0% | 0% | 23.7% |
| Profitability | 0% | 20% | 15% | 100% |
| Total debt ratio | 168.6% | 93.47% | 94.09% | 24.56% |
| Debt ratio change over time | 0% | 0% | 0% | -0.62% |
| Dept financing | 50% | 14% | 14% | 4% |
| Current Ratio | 1.59% | 0.9% | 1.54% | 3.64% |
| Quick Ratio | 0% | 0.8% | 1.06% | 3.42% |
| Cash Position Ratio | 0.52% | 0.39% | 0.54% | 2.77% |
| Liquididy | 16% | 16% | 23% | 75% |